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Abstract Aseptic loosening secondary to periprosthetic in-
flammatory osteolysis results from the biological response to
wear particles and is a leading cause of arthroplasty failure.
The origin of this inflammatory response remains unclear. We
aim to validate the definite link between endoplasmic reticu-
lum (ER) stress and particle-induced inflammatory signaling
pathways in periprosthetic osteolysis. We examine the histo-
pathologic changes of osteolysis and the expression of specif-
ic biomarkers for ER-stress-mediated inflammatory signaling
pathways (IRE1α, GRP78/Bip, c-Fos, NF-κB, ROS and
Ca2+). Moreover, pro-inflammatory cytokines (TNF-α, IL-
1β and IL-6) and osteoclastogenic molecules (VEGF, OPG,
RANKL and M-CSF) were assessed in clinical interface
membranes and murine periosteum tissues. We found wear
particles to be capable of inducing ER stress in macrophages
within clinical osteolytic interface membranes and murine
osteolytic periosteum tissues and to be associated with the
inflammatory response and osteoclastogenesis. Blocking ER
stress with sodium 4-phenylbutyrate (4-PBA) results in a dra-
matic amelioration of particle-induced osteolysis and a signif-
icant reduction of ER-stress intensity. Simultaneously, this
ER-stress blocker also lessens inflammatory cell infiltration,
diminishes the capability of osteoclastogenesis and reduces
the inflammatory response by lowering IRE1α, GRP78/Bip,
c-Fos, NF-κB, ROS and Ca2+ levels. Thus, ER stress plays an
important role in particle-induced inflammatory osteolysis
and osteoclastogenic reactions. The pharmacological targeting
of ER-stress-mediated inflammatory signaling pathways
might be an appealing approach for alleviating or preventing
particle-induced osteolysis in at-risk patients.
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Introduction
Total joint replacement by the implantation of a permanently
in-dwelling artificial prosthesis is a revolutionary surgical pro-
cess for enhancing the agility of a patient with joint dysfunc-
tion (Klawitter et al. 2011; Rubak et al. 2014; Wooley and
Schwarz 2004). However, aseptic loosening secondary to
periprosthetic osteolysis, induced by the ensuing adverse bio-
logical responses to wear particles, can jeopardize the longev-
ity and prolonged efficacy of the prosthetic components (Beck
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et al. 2012; Noordin and Masri 2012; Park et al. 2005; Purdue
et al. 2006). Wear particles originating at the prosthesis inter-
face can become distributed along the periprosthetic ambience
and can occupy neighboring tissues in which they are phago-
cytosed by tissue-resident cells (Jasty and Smith 1992). These
activated cells then secrete an array of pro-inflammatory cy-
tokines (tumor necrosis factor-α [TNF-α], interleukin-1β [IL-
1β], and IL-6), osteoclastogenic molecules (vascular endothe-
lial growth factor [VEGF], osteoprotegerin OPG, receptor ac-
tivator of nuclear kaapa B [RANKL] and macrophage/colony-
stimulating factor [M-CSF]) and other mediators of inflamma-
tion. This exacerbates the osteolytic responses via multiple
biological functions, including the progression of an aggres-
sive interface membrane adjacent to the bone, the differentia-
tion of macrophages into lacunar bone-resorbing osteoclasts
and the emancipation of the cytokines mentioned above to
attract and enlist additional inflammatory cells that liberate
more pro-inflammatory cytokines, osteoclastogenic cytokines
and other mediators of inflammation. The cascade perpetuates
a positive feedback cycle of inflammation and osteoclastogen-
esis activation (Burton et al. 2013; Dalal et al. 2012; Ingham
and Fisher 2005; Jiang et al. 2013a; Obando-Pereda et al.
2014; Raghunathan et al. 2013; Shimizu et al. 2010; Wang
et al. 2010). Eventually, considerable amounts of osteoclast
precursor cells and osteoclasts are enlisted and/or activated to
absorb the bone, a process that leads to local progressive bone
destruction and finally prosthesis loosening.
Accumulating evidence (Goodman et al. 1998; Ingham and
Fisher 2005; Jiang et al. 2013b; Kadoya et al. 1998; O’Neill
et al. 2013; Obando-Pereda et al. 2014; Shen et al. 2006;
Shimizu et al. 2010) has demonstrated that the integral ele-
ments underlying bone destruction in periprosthetic osteolysis
are macrophages in the osteolytic interface membrane. These
cells are mainly involved in inflammation and osteoclastogen-
esis and have been implicated in the principle pathophysiolog-
ic mechanism leading to the development of particle-induced
osteolysis. In addition, investigators (Archibeck et al. 2001;
Hirashima et al. 2001; Katagiri and Takahashi 2002; Pearle
et al. 2007; Teitelbaum 2006) have previously confirmed that
macrophages can be recruited to the interface membrane
around loosening prostheses by particle-induced continuous
inflammation. Moreover, tissue-resident macrophages might
be able to differentiate into osteoclasts, which are in charge
of osteolysis. Therefore, we considered it probable that mac-
rophages represent both the origin and the impetus for the
pathogenic cascade in osteolysis. Thus, the interaction between
macrophages and wear particles in the osteolytic interface
membrane is probably the factor deciding whether the
particle-induced inflammatory response will be dissipated or
will develop into irreversible periprosthetic osteolysis.
Over the past few years, many reports have been focused
on the various functions of the various cytokines and macro-
phages (Caruso et al. 2014; Geng et al. 2010b; Jin et al. 2011;
Lee et al. 2013; Lin et al. 2014; Mao et al. 2012) and our
understanding of the cellular and molecular mechanisms con-
trolling particle-induced inflammatory osteolysis has rapidly
improved (Abu-Amer et al. 2007; Caruso et al. 2014; Clohisy
et al. 2004; Geng et al. 2010a; Kong et al. 2013; Landgraeber
et al. 2009, 2014; Lee et al. 2013; Li et al. 2014; Liu et al.
2009, 2014; Mao et al. 2012; Shetty et al. 2005; Wang et al.
2013; Zhai et al. 2014). However, the way that inflammatory
osteolysis originates is not completely understood. A new and
attractive underlying mechanism involves the endoplasmic
reticulum (ER; Cao and Kaufman 2014; Gorlach et al. 2006;
Hotamisligil 2010; Lai et al. 2007; Marciniak and Ron 2006),
which is the main cellular site for the folding and trafficking of
protein and vital for many molecular functions. As a common
pathway of many stress processes, ER is a potentially prom-
ising emerging treatment target, partly because its adaptive
mechanisms have no time to handle the sustained stresses
suffered because of the continuous generation of wear parti-
cles in the periprosthetic space. In addition, ER is intercon-
nected with inflammatory signaling pathways by the unfolded
protein response and ER stress. Notably, studies assessing the
unfolded protein response and ER stress have extended the
comprehension of possible mechanisms by which inflamma-
tory signaling pathways can originate (Cao and Kaufman
2014; Gao et al. 2012; Lai et al. 2007; Zhang and Kaufman
2008). The branches of representative ER stress intersect with
sundry inflammatory signaling systems, including the activa-
tion of the IRE1α/JNK/c-Fos-AP-1 and nuclear factor kappa
B (NF-κB) pathways, release of Ca2+ from the ER and
reactive-oxygen species (ROS) production.
Recently, researches (Christen and Fent 2012; Tsai et al.
2011; Wang et al. 2013; Zhang and Kaufman 2008; Zhang
et al. 2012) have shown that the cell fate and growth in the
interface membrane, influenced by wear particles, are activat-
ed in response to ER stress; in addition, prolonged and endur-
ing ER stress is thought to be essential to the pathogenesis of
inflammatory diseases. However, previous work has provided
only a limited viewpoint regarding the influence of ER stress
on inflammatory osteolysis and reports describing the straight
effect of ER stress on particle-induced inflammation and os-
teoclastogenesis are scarce. Thus, we hypothesized that
particle-induced inflammatory signaling pathways within
the osteolytic interface membrane in periprosthetic
osteolysis are mediated by ER stress and that the inhibi-
tion of the ER-stress response in osteolytic tissue macro-
phages, which can further cause changes in particle-
induced inflammation and osteoclastogenesis, is undoubt-
edly a good therapeutic option. Therefore, in our study,
we determined the potential effect of ER stress on wear-
particle-induced osteolysis, osteoclastogenesis and macro-
phage inflammation within osteolytic tissues in an effort
to identify the mechanism of the inflammatory response
caused by wear particles.
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Materials and methods
Ethics statement
This study conducted in Jinling Hospital affiliated to the
School of Medicine, Nanjing University (China) was ap-
proved by the local ethics institutional review board (Jinling
Hospital Ethics Committee). Written informed consent was
obtained from each participant or from guardians in the case
of minors. In addition, all animal studies were approved by the
Committee on the Ethics of Animal Experiments of Nanjing
University (permit no. 2011–039) and followed BThe
Institutional Guidelines for the Care and Use of Laboratory
Animals at Nanjing University .^ The surgical procedure was
implemented under sodium pentobarbital anesthesia and all
endeavors were undertaken to minimize suffering.
Reagents
Bovine serum albumin (BSA), 4-phenylbutyric acid (4-PBA),
thapsigargin (Tg) and a cocktail of protease inhibitors were all
purchased from Sigma-Aldrich (St. Louis, Mo., USA). RIPA
lysis buffer was purchased from Beyotimme (Nantong,
China). The toluidine blue and hematoxylin and eosin (HE)
staining kits were purchased from Jiancheng Biotech
(Nanjing, China). Enzyme-linked immunosorbent assay
(ELISA) kits for examining mouse/human TNF-α, IL-1β,
IL-6 and M-CSF were purchased from 4A Biotech (Beijing,
China). Primary antibodies to OPG and RANKL used in im-
munohistochemistry were purchased from Abcam (USA).
Primary antibodies to VEGF (immunohistochemistry) were
purchased from Santa Cruz (USA).
Particle preparation
Nanoparticles of TiAl6V4 (TiNPs) and CoCrMo (CoNPs),
provided by Dr. Zhenzhong Zhang (College of Materials
Science and Engineering of Nanjing University of
Technology), had a mean diameter of 51.7 nm as determined
by transmission electron microscopy (TEM). Metal nanopar-
ticles were manipulated in an aseptic milieu. Briefly, particles
were washed five times with 70 % ethanol and incubated for
48 h for sterilization at ambient temperature. Then, the metal
nanoparticles were cleaned with phosphate-buffered saline
(PBS) three times, dried in a desiccator and resuspended to
20mg/ml (stock solution). Solutions of various concentrations
were well dispersed in cell culture medium by sonication for
10 min by using Shumei KQ218 (100 w) Ultrasonic Cleaning
equipment (Kunshan Ultrasonic Instruments, Jiangsu, China).
All the particles were endotoxin-free, as determined by a
quantitative Limulus Amebocyte Lysate (LAL) assay
(Charles River, Grand Island, USA) at a detection level of
0.25 % EU/ml.
Particle-induced murine calvarial osteolysis model
A well-established and widely used model for studying
particle-induced osteolysis is the murine calvarial resorption
model (Dong et al. 2008; Wang et al. 2013) in which wear
particles and other stimuli are placed onto the cranium and
their effect on the calvaria is directly assessed. Based on our
research purpose and previous studies (Billi and Campbell
2010; Cobb and Schmalzreid 2006; Gill et al. 2012;
Polyzois et al. 2012; Tsai et al. 2011; Wang et al. 2013), we
introduced the TiAl6V4 (TiNPs) and CoCrMo (CoNPs) nano-
particles (51.7 nm in diameter) to investigate the relationship
between particle-induced osteolysis and the ER-stress-
mediated inflammatory response within osteolytic tissues in
the periprosthetic space. Tg (a classic ER-stress inducer) and
4-PBA (a classic ER-stress blocker) were also employed in the
experiments.
Mice weighed 20–25 g at the start of the experiments and
techniques described previously were used to construct
calvarial models. A total of 70 female C57BL/J6 mice (12–
14 weeks old) were randomly divided into seven experimental
groups (n=10) evaluated at the Experimental Animal Center
of Nanjing University (Nanjing, China): group I, sham sur-
gery controls; group II, TiNPs implantation; group III, TiNPs
+ 4-PBA co-treatment; group IV, TiNPs + Tg co-intervention;
group V, CoNPs implantation; group VI, CoNPs + 4-PBA co-
treatment; group VII, CoNPs + Tg co-intervention. As previ-
ously described, the mice were anesthetized for the dissection
of the cranial periosteum from the calvaria. Then, 40 μl
TiNPs/CoNPs suspensions with/without Tg (106 nmol/l) in
PBS was spread uniformly under the intact periosteum in the
intermediate gap of the cranium. Mice in the 4-PBA groups
were injected intraperitoneally with 4-PBA at 300 mg/kg on
days 0, 1, 2, 3 and 5 post-surgery.
Specimen retrieval and histological processing of murine
calvarial osteolysis model
The animals were killed in a carbon dioxide chamber at
2 weeks after particle implantation. The calvarial caps were
gathered by dissection of the bone from the underlying brain
tissue and removal of an elliptical plate of bone bound from
the area between the foramina magnum and auditory canals.
Then, after being trimmed in half along the midline of the
calvaria caps, one half was preserved in pre-cooled PBS for
toluidine blue staining, whereas the other was used for HE
staining. In addition, osteolytic periosteum tissues were col-
lected and weighed with an analytical balance. One-third was
ground in liquid nitrogen and lysed in RIPA lysis buffer in the
presence of protein inhibitor cocktails, with the final superna-
tants being stored at −80 °C for Western blotting and quanti-
tation of Ca2+ concentration, ROS level and tartrate-resistant
acid phosphatase (TRAP) activity. Another third was
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homogenized with a high-speed blender in a medium contain-
ing appropriate RIPA lysis buffer with protein inhibitor cock-
tails and the final supernatants were stored at −80°C for
ELISA detection. The last third was fixed in 4 % paraformal-
dehyde for 24 h and the paraffin-embedded tissues were proc-
essed for immunohistochemistry. In addition, osteolytic
calvarial tissues were also collected for TRAP activity
determination.
Periprosthetic osteolytic bone tissues and interface
membrane specimens
Periprosthetic osteolytic bone tissues and interface membrane
specimens were obtained at revision operations from patients
with periprosthetic osteolysis and aseptic loosening, after in-
fection was ruled out. The unloose specimens came from the
acetabulum cup of a patient who underwent a revision opera-
tion because of mechanical loosening. Capsule samples from
a patient undergoing primary total hip replacement for hip
dysplasia served as a control. The clinical data of all patients
are shown in Table 1. The interface membrane specimens
were collected for TEM, Western blotting, ELISA, immuno-
histochemistry and determination of Ca2+ concentration, ROS
level and TRAP activity. In addition, osteolytic bone tissues
were also collected for TRAP activity evaluation.
Transmission electron microscopy
Osteolytic interface membrane specimens for TEMwere fixed
in 2.5 % glutaraldehyde in 0.1 mol/l phosphate buffer (pH 7.4)
for 1 day and post-fixed in 1 % osmium tetroxide. The fixed
specimens were then dehydrated through a graded ethanol
series and embedded in Epon 618 (TAAB Laboratories
Equipment, Berks., UK). Ultrathin sections were stained with
lead citrate and uranyl acetate. Images were captured by a
TEM (Philip CM-120) operated under normal atmospheric
pressure and temperature.
Micro-computed tomography scanning
Qualitative and quantitative osteolysis analyses were car-
ried out in mouse calvaria by a high-distinguishability
micro-computed tomography (micro-CT) scanner
(SkyScan1176; SkyScan, Aartselaar, Belium). An equi-
distant resolution at 18 μm was used in the scanning
protocol, with X-ray energy settings of 45 kV and
550 μA. To reduce negative effects of metal nanoparti-
cles, TiNPs and CoNPs were eliminated before scanning.
After reconstruction, the osteolytic region was selected
for further analyses. The percentage of total porosity of
each calvaria sample was measured as previously reported
(Liu et al. 2014).
Histology and immunohistochemistry
Bone resorption studies were performed on calvaria by
using the toluidine blue staining assay. Briefly, the calvaria,
whose surfaces were cleanly removed, were placed in
0.25 % trypsin for 15 min and remained overnight in
0.25 M ammonium hydroxide before being stained with
0.25 % toluidine blue for 15 min. Slices were trimmed
and mounted on slides with buffering glycerin after vigor-
ous washes and air-drying. A light microscope (Nikon
TE2000U, Nikon, Tokyo, Japan) was used to observe the
extent of lacunar absorption by calculating the number of
absorption pits.
The interface membrane and calvaria tissue sections were
stained with HE for standard histological analysis of inflam-
matory infiltration. Briefly, the paraformaldehyde-fixed and
paraffin-embedded sections from the retrieved tissues were
sliced at a thickness of 4 μm and stained with HE solution.
Four separate sections per sample were assessed in an unbi-
ased manner. The positive cells for targeted protein in
immunohistological sections were counted via Image-Pro
Plus analysis software 6.0 (Media Cybernetics, Silver
Spring, Md., USA).
Table 1 Clinical data of patients (F female,Mmale, Cup acetabular cup,UNL unloose specimen, LOO1–6 loose specimens 1–6). UNL and LOO1–6
specimens were collected from the interface of the bone and the artificial femoral head
Case Gender Age (years) Pre-operative diagnosis Years after implantation Type of fixation Specimen collection site
Control F 17 Hip dysplasia – – Acetabulum
UNL M 74 Mechanical loosening 10 Cementless Cup
LOO1 M 47 Aseptic loosening 24 Cementless Cup
LOO2 M 66 Aseptic loosening 17 Cementless Cup
LOO3 F 72 Aseptic loosening 3 Cementless Cup
LOO4 M 67 Aseptic loosening 10 Cementless Cup
LOO5 M 49 Aseptic loosening 17 Cementless Cup
LOO6 M 49 Aseptic loosening 17 Cementless Cup
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Western blotting
The retrieved interface membrane and periosteum tissues were
crushed and ground in RIPA lysis buffer (50 mM TRIS, pH
7.4, 150 mM NaCl, 1 % sodium deoxycholate, 1 % Triton
X-100, 0.1 % SDS, 1 mM phenylmethane sulfonyl-fluoride)
including a cocktail of protease inhibitors; the resulting lysate
was cleared by centrifugation at 12,000g for 8 min at 4 °C.
The supernatants were then collected and determined with a
BCA protein assay kit (Biocolor Bioscience and Technology,
Shanghai, China) to examine the protein concentration.
The supernatant equivalent of 100 μg protein was electro-
phoresed on 10 % sodium dodecyl sulfate polyacrylamide
gels and transferred onto nitrocellulose membranes. After
non-specific blocking with skimmilk, the nitrocellulose mem-
branes were incubated, respectively, with rabbit polyclonal
antibodies raised against GRP78/Bip, IRE1-α, rabbit poly-
c lona l an t i body aga in s t NF-κB, c -Fos and D-
glyceraldehyde-3-phosphate dehydrogenase (Cell Signaling
Technology, Beverly, Mass., USA). Subsequently, anti-rabbit
IgG secondary antibodies conjugated to horseradish peroxi-
dase (Santa Cruz, Calif., USA) were applied. After determi-
nation of the formula weight of the purified protein by SDS
polyacrylamide gel electrophoresis, the band was excised
from the gel for protein identification by using a chemilumi-
nescence detection system (Cell Signaling Technology). Band
density was analyzed by using ImageJ 1.41 (National
Institutes of Health, Bethesda, Md., USA).
Determination of Ca2+ levels
Ca2+ concentrations in the interface membrane and perioste-
um tissues were measured by colorimetric assays by using a
Calcium Detection Kit (Abcam, USA). The experimental pro-
cedure was in accordance with the manufacturer’s instruc-
tions. Briefly, 90 μl color-developing agent and 60 μl calcium
assay buffer were blended in each well containing 50 μl sam-
ple and mixed gently. The reaction was incubated for 5–
10 min at room temperature in the dark. Absorbance was
measured at 575 nm and the final results were normalized to
total cell protein and presented as millimols per gram protein.
Results represent the means ± SD of three experiments per-
formed in duplicate.
ROS level determination
The intracellular ROS levels in the interface membrane and
periosteum tissues were detected by the ROS-specific fluores-
cent probe 2-,7-dichlorofluorescin diacetate (DCFH-DA;
Beyotime, China). All procedures were performed in accor-
dance with the manufacturer’s instructions. Values were ob-
tained at 488 nm excitation and 525 nm emission. The chang-
es in absorbance rate were directly proportional to the ROS
levels. The final values were normalized to total cell protein
and the results are presented as the means ± SD of three ex-
periments performed in duplicate.
Tissue TRAP activity and ELISA
TRAP activity in osteolytic bone, calvaria, interface mem-
brane and periosteum tissues was determined by using a tissue
TRAP Quantification Kit from Jiancheng Biotech (Nanjing,
China). Inflammatory factors (TNF-α, IL-1β, IL-6 and M-
CSF) present in the osteolytic interface membrane and perios-
teum tissues were quantified by using specific ELISA kits. All
processes were carried out in accord with the manufacturer’s
instructions. Total protein levels were used for normalization.
Immunohistochemistry
Samples of the interface membrane and periosteum were sec-
tioned into 4-μm-thick slices and mounted on protein-coated
slides. The expression of VEGF, OPG and RANKL was ana-
lyzed by using immunohistochemical staining of the
osteolytic interface membrane and periosteum tissues. After
the blocking of endogenous peroxidase activity and immer-
sion of the sections in antigen retrieval buffer, they were incu-
bated with primary antibodies raised against VEGF, OPG and
RANKL at 4 °C overnight and then washed three times. The
ChemMate EnVision/horeseradish peroxidase solution was
mixed, brought to ambient temperature and applied to the
sections. Color was developed by adding diaminobenzidine
solution, plus counterstaining with hematoxylin. The sections
were analyzed to obtain the percentage of cells stained posi-
tively for the target protein in various specimens. Eight ran-
domly selected areas were analyzed for each immunostaining.
Micrographs were acquired and the total count of positive
cells was derived by using Image Pro Plus software (Media
Cybernetics, Silver Spring, MD, USA).
Statistical analysis
Data are presented as means ± standard error of the mean
(SEM). Differences in the average of the variables of experi-
mental parameters between groups were evaluated by analysis
of variance (ANOVA). Post hoc testing of the differences be-
tween each group was implemented by utilizing Duncan’s test
when the ANOVA was substantial. A P-value <0.05 was
deemed to be a significant difference. No adjustment for mul-
tiple testing was applied since the statistical analysis was per-
formed in an exploratory way. Statistical analyses were proc-
essed with the SPSS v17.0 software package (SPSS, Chicago,
Ill., USA).
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Results
Histopathologic changes of osteolysis mediated
by particle-induced ER stress
To address the effect of ER stress on osteolysis and to inves-
tigate the relationship between particle-induced osteolysis and
the ER-stress-mediated inflammatory response in osteolytic
tissues of the periprosthetic space, we produced a particle-
induced bone resorption animal model to evaluate directly
the impact of ER stress on particle-induced osteolysis. Based
on previous studies and our TEM data, we introduced
TiAl6V4 (TiNPs) and CoCrMo (CoNPs) nanoparticles, with
Tg and 4-PBA being used as an ER-stress inducer and
blocker, respectively. In the murine model of periprosthetic
osteolysis, no deaths were noted during or after the implanta-
tion of TiNPs and CoNPs andmicemaintained normal activity
throughout the study. At 2 weeks after calvarial bone implan-
tation of TiNPs and CoNPs, mice were killed and the histo-
pathologic changes of particle-induced osteolysis were evalu-
ated by micro-CT scanning and toluidine blue staining.
As expected, implantation of TiNPs and CoNPs induced
serious bone resorption, as evidenced by the vast areas of
surface corrosion observed on the cranium, compared with
the sham surgery controls, which had no implantation of wear
particles (Fig. 1a–h). By contrast, the blocking of ER stress
with 4-PBA significantly reduced wear-particle-induced bone
erosion and destruction. However, the total bone porosity of
osteolytic calvaria was exacerbated by co-administration of
the ER-stress-inducer Tg (Fig. 1a–h). Histological and
histomorphometric analyses after toluidine blue staining fur-
ther verified the remission of particle-induced bone resorption
and destruction by 4-PBA. The degree of lacunar resorption
was characterized by calculating the number of resorption pits.
As shown in Fig. 1a’–h’, wear-particle implantation resulted
in considerable toluidine-blue-positive bone resorption lacu-
nae in the calvarial caps. Consistent with the micro-CT quan-
titation, histological analysis demonstrated that 4-PBA co-
treatment significantly decreased the bone resorption induced
by wear particles, whereas the osteolysis areas were markedly
increased after TiNPs or the CoNPs and Tg combination
(Fig. 1a’–h’). Collectively, these data revealed a key role for
ER stress in particle-induced bone erosion and destruction,
thus indicating that the blocking of ER stress with a specific
inhibitor might be an effective anti-bone resorptive mecha-
nism for the therapy of particle-induced osteolysis.
Involvement of ER stress in osteolytic periosteum tissues
taken from animal models of periprosthetic inflammatory
osteolysis
To investigate whether ER stress was involved in osteolytic
periosteum tissues, we monitored the expression of ER-stress-
associated molecules IRE1α and GRP78/Bip by Western blot
(Fig. 2a–d) and assessed Ca2+ leakage by using colorimetric
assays (Fig. 2e). As expected, the expression levels of the ER-
stress markers (IRE1-α, GRP78/Bip and Ca2+) in osteolytic
periosteum tissues were all significantly increased as
osteolysis progressed following the implantation of TiNPs
and CoNPs (Fig. 2a–e). However, ER-stress induction by
TiNPs and CoNPs was overtly suppressed by co-treatment
with 4-PBA (Fig. 2a–e). In contrast, co-administration of
TiNPs or of CoNPs and Tg induced higher ER stress com-
pared with treatments with each product alone (Fig. 2a–e).
Thus, these data imply that wear particles are capable of in-
ducing ER stress and Ca2+ mobilization in osteolytic perios-
teum tissues from animal models of periprosthetic inflamma-
tory osteolysis (PIO).
ER-stress-mediated inflammatory response in osteolytic
periosteum tissues from PIO animal models
An inspection of ER stress demonstrated many links to the in-
flammatory pathways, including networks activated by oxidative
stress (ROS) and Ca2+ and the NF-κB and IRE1α/JNK/c-Fos -
AP-1 pathways. As described above, we demonstrated that wear
particles induce ER stress via IRE1α, GRP78/Bip and Ca2+,
exacerbating bone resorption when phagocytosed by macro-
phages in osteolytic periosteum tissues taken from PIO animal
models. Therefore, to investigate whether particle-induced
osteolysis and ER stress are relevant to the inflammatory re-
sponse, we next assessed the expression of pro-inflammatory
cytokines (TNF-α, IL-1β and IL-6) by ELISA (Fig. 2f–h), ana-
lyzed inflammatory cell infiltration and membrane erosion by
using HE staining (Fig. 2a’–h’), examined c-Fos and NF-κB
expression levels by Western blot (Fig. 3a–d) and assessed
ROS release by using fluorescent probes (Fig. 3e).
As shown in Fig. 2f–h, the implantation of TiNPs and
CoNPs induced severe inflammation, as determined by the
significantly increased TNF-α, IL-1β and IL-6 levels, com-
pared with negative controls. In contrast, co-treatment with 4-
PBA significantly reduced the expression of wear-particle-
induced inflammatory cytokines (Fig. 2f–h), However,
TNF-α, IL-1β and IL-6 levels in the Tg co-intervention
groups showed a completely opposite trend to those obtained
for the 4-PBA co-treatment groups (Fig. 2f–h).
Histological analysis of HE-stained osteolytic calvaria fur-
ther confirmed the reduction of particle-induced inflammation
by 4-PBA (Fig. 2a’–h’). Generally, the morphology of control
mouse calvaria was smooth and seldom manifested bone ero-
sion and inflammatory cells infiltrates (Fig. 2a’–h’). Bone and
inf lammatory cel ls were ident i f ied according to
histomorphologic criteria. Normally, osteoblast clusters were
found in bone matrix juxtaposing the mouse calvaria, whereas
inflammatory cells remained on the surface and corroded the
calvarial surface (Fig. 2a’–h’). In PIO animal models,
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implantation of TiNPs and CoNPs induced extensive inflam-
matory infiltrates, as evidenced by pronounced inflammatory
cell infiltration along the eroded bone surface compared with
negative controls (Fig. 2a’–h’). In addition, the bone morphol-
ogy remained intact in controls, whereas increased surface
bone erosion was observed in osteolytic calvarial tissues after
particle implantation (Fig. 2a’–h’). However, 4-PBA co-treat-
ment significantly reduced particle-induced bone erosion and
inflammatory infiltrates (Fig. 2a’–h’). By contrast, chaotic
bone morphology, extensive bone erosion and frequent in-
flammatory cell infiltration were significantly exacerbated
by Tg co-intervention (Fig. 2a’–h’). Together with the
micro-CT (Fig. 1a–h) and toluidine blue staining (Fig. 1a’–
h’) results, these data suggest that wear particles promote
osteolysis and inflammatory infiltrates and have an effect
highly dependent on ER-stress induction.
Next, we explored whether the expression of c-Fos and
NF-κB were induced in the periosteum following the various
treatments. As expected, a significant increase in c-Fos and
NF-κB expression levels was induced after implantation of
TiNPs and CoNPs representing wear particles (Fig. 3a–d). In
addition, significant differences in c-Fos and NF-κB expres-
sion levels were obtained between the ER-stress inducer (Tg)
and ER-stress blocker (4-PBA) groups (Fig. 3a–d). Indeed, c-
Fos and NF-κB expression levels were overtly increased with
Tg co-administration but were notably inhibited by 4-PBA co-
treatment, following TiNPs and CoNPs implantation (Fig. 3a–
d). The above results revealed that c-Fos and NF-κB expres-
sions were mediated by ER stress and that the inhibition of ER
stress could limit c-Fos and NF-κB production in osteolytic
periosteum tissues.
Furthermore, we examined the ROS activities in osteolytic
periosteum tissues and found that they increased as osteolysis
progressed following the implantation of TiNPs and CoNPs
(Fig. 3e). However, ROS activity levels after implantation of
TiNPs and CoNPs were markedly inhibited by co-
Fig. 1 Histological changes of osteolysis mediated by particle-induced
endoplasmic reticulum (ER) stress (TiNPs TiAl6V4 nanoparticles,
CoNPs CoCrMo nanoparticles, Tg thapsigargin, 4-PBA 4-
phenylbutyrate). a–h Representative microtomography images of the
calvaria in each group (arrows calvaria surface corrosion). a’–h’
Toluidine blue staining of the calvaria in each group (arrowheads bone
resorption lacunae). Original magnification: ×40. Bar 500 μm. Data rep-
resent means ± SEM for each group. *P<0.05, **P<0.01 versus control.
#P<0.05, ##P<0.01 versus TiNPs or CoNPs
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administration of 4-PBA (Fig. 3e). By contrast, the effects were
significantly aggravated by co-intervention with Tg (Fig. 3e).
Thus, the results obtained above demonstrated that the in-
flammatory response in osteolytic periosteum tissues was in-
duced by wear particles, a predominantly ER-stress-mediated
effect. Moreover, the inhibition of ER stress effectively re-
duced the inflammatory response in osteolytic periosteum tis-
sues from PIO animal models.
Expression of ER-stress-mediated osteoclastogenic
molecules in osteolytic periosteum tissues from PIO
animal models
Previous studies have revealed that osteoclasts differentiation is
dependent on M-CSF and RANKL, whose expression is up-
regulated during osteoclast differentiation. VEGF, the most po-
tent angiogenic growth factor, plays an important role in particle-
induced inflammation and osteoclast differentiation.
Simultaneously, inflammatory and osteoclastogenic pathways al-
so have crosslinks in their associated signaling cascades, includ-
ing the IRE1α/JNK/c-Fos-AP-1 and NF-κB pathways. Given
our findings that particle-induced GRP78/Bip and IRE1α
(Fig. 2a–d), c-Fos and NF-κb (Fig. 3a–d) expression levels were
obviouslymediated by ER stress, we hypothesized that ER stress
might also be responsible for the expression of osteoclastogenic
enzymes and molecules, such as M-CSF, TRAP, VEGF, OPG
and RANKL. To test this hypothesis, tissue levels of M-CSF,
TRAP, VEGF, OPG and RANKL were assessed.
As shown in Fig. 3f, a low expression of M-CSF was ob-
served in normal periosteum tissues. Implantation of TiNPs
Fig. 2 ER stress, pro-inflammatory cytokines and hematoxylin and eosin
(HE) staining in animal models of periprosthetic inflammatory osteolysis
(PIO). a-dWestern blots of IRE1α and Grp78/BiP in periosteum tissues
performed after animals were treated with various stimuli. The density of
the Western blot bands was quantified by using ImageJ software (GADH
D-glyceraldehyde-3-phosphate dehydrogenase). e-h Ca2+ content (e) and
the expression of pro-inflammatory cytokines tumor necrosis factor-α
(TNF-α, f), interleukin-1β (IL-1β, g) and interleukin-6 (IL-6, h) in
periosteum tissues after animals were treated with various stimuli. a’–h’
HE staining of the calvaria in each group. Infiltration of inflammatory
cells was observed in the calvaria. Inflammatory cells (arrows) and oste-
oclasts (arrowheads) were identified according to histomorphologic
criteria. Original magnification: ×200. Bar 100 μm. Data represent the
means ± SEM from three independent experiments. +P<0.05, ++P<0.01
versus control. #P<0.05, ##P<0.01 versus TiNPs or CoNPs
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and CoNPs, however, resulted in large M-CSF amounts. In
addition, M-CSF content was highest in the Tg co-
intervention group and was drastically reduced when animals
were co-treated with 4-PBA (Fig. 3f).
To investigate whether the effects of osteolysis caused
by ER stress in vivo were relevant to the increased oste-
oclast number, TRAP quantification kits were used to de-
termine the capabilities of osteoclastogenesis in osteolytic
periosteum (Fig. 3g) and bone (Fig. 3h) tissues. In addi-
tion, we also compared the number of osteoclasts among
the various treatment groups by histochemical staining for
TRAP, a cytochemical marker for osteoclasts (Fig. 4a–h).
We found that TRAP activity and osteoclast numbers fol-
lowing TiNPs and CoNPs implantation were higher than
those of negative controls. Consistent with our M-CSF
data (Fig. 3f), the effects were suppressed by co-
t rea tment wi th 4-PBA and exacerba ted by co-
administration of Tg (Figs. 3g, h, 4a–h), suggesting that
the differentiated osteoclasts were significantly increased
by exposure to wear particles and that ER stress is in-
volved in particle-induced osteoclastogenesis in PIO ani-
mal models.
We next searched for cells positive for VEGF (Fig. 4a’–h’),
OPG (Fig. 5a–h) and RANKL (Fig. 5a’–h’) in retrieved
osteolytic periosteum tissues by means of immunohistochem-
istry. The numbers of macrophages positive for VEGF
(Fig. 4a’–h’) and RANKL (Fig. 5a’–h’) significantly in-
creased after TiNPs and CoNPs implantation, whereas their
frequency in normal tissues was lower compared with
osteolytic periosteum tissues. To investigate further whether
particle-induced VEGF and RANKL expression resulted from
ER stress, we examined the effect of Tg and 4-PBA on
particle-induced VEGF and RANKL expression levels. As
expected, cells positive for VEGF and RANKL were most
intensive in the TiNPs or CoNPs plus Tg co-intervention
groups and the effects were reduced starkly in the 4-PBA
co-treatment group (Figs. 4a’–h’, 5a’–h’). In addition, the
trend of OPG changes was different from those of VEGF
and RANKL. As shown in Fig. 5a–h, only a few positive cells
were observed in the osteolytic periosteum tissues following
the implantation of TiNPs and CoNPs compared with normal
tissues. However, OPG expression was highly expressed in
the TiNPs or the CoNPs plus 4-PBA co-treatment groups
(Fig. 5a–h).
Given that the RANKL/OPG ratio is suitable for estimating
osteolysis, the quantitative analysis of RANKL and OPG was
examined byWestern blot. The RANKL and OPG expression
levels obtained by Western blot (Fig. 5a’’–d’’) corroborated
the immunohistochemistry data (Figs. 5a–h, a’–h’). In addi-
tion, this ratio was obviously increased in the TiNPs and
CoNPs groups, compared with the PBS control group
(Fig. 5a’’–d’’). The RANKL/OPG ratio in the Tg co-
intervention group was only slightly increased compared with
the PBS control group but was slightly decreased compared
with that in the osteolytic periosteum tissues implanted with
TiNPs and CoNPs (Fig. 5a’’–d’’). In addition, the RANKL/
OPG ratio after 4-PBA co-administration was overtly de-
creased compared with that of the TiNPs and CoNPs groups
(Fig. 5a’’–d’’).
Collectively, these findings suggested that the produc-
tion of osteoclastogenic molecules in osteolytic periosteum
tissues from PIO animals was mediated by ER stress and
that the blocking of ER stress with 4-PBA could impair
osteoclastogenesis.
Fig. 3 ER-stress-mediated nuclear factor kappa B (NF-κB) and c-Fos,
reactive oxygen species (ROS), macrophage/colony-stimulating factor
(M-CSF) and tartrate-resistant acid phosphatase (TRAP) activity in
osteolytic periosteum tissues from PIO animal models. a-dWestern blots
of NF-κB and c-Fos in periosteum tissues performed after animals were
treated with various stimuli. The density of the Western blot bands was
quantified by using ImageJ software. e-h ROS content (e), M-CSF con-
tent (f) and TRAP activity (g) in periosteum tissues and TRAP activity in
calvaria tissues (h) after animals were treated with various stimuli. The
data represent the means ± SEM from three independent experiments. +
P<0.05, ++P<0.01 versus control. #P<0.05, ##P<0.01 versus TiNPs or
CoNPs
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Pre-operative X-ray examination and tissue
ultrastructural analysis
Pre-operative X-rays of patients are shown in Fig. 6a, b.
Patients in our study all showed definite osteolysis and loos-
ening signs in X-rays. In our study, we found that the extent of
bone resorption evaluated by intra-operative observation was
in agreement with pre-operative radiographs and the implan-
tation time of the revision patient. In addition, the ultrastruc-
ture of the osteolytic interface membrane tissues was revealed
by TEM. As shown in Fig. 6c, a large number of black metal
wear particles were found in osteolytic interface membrane
tissues. They were mainly of a rounded outward appearance,
with smooth edges and a diffuse distribution and accumulated
into agglomerations. Analysis of TEM images revealed that
the particles were in the nanometer range, with the majority
showing a size of 30–60 nm. In addition, the size distribution
of these wear particles within the osteolytic interface mem-
brane tissues in our study was in accordance with previous
reports.
Involvement of ER stress in clinical osteolytic interface
membrane tissues
To investigate whether ER stress is involved in the
osteolytic interface membrane, we examined IRE1α,
GRP78/Bip and Ca2+ levels in clinical specimens. As ex-
pected, IRE1-α and GRP78/Bip expression levels in the
osteolytic interface membrane were all significantly in-
creased compared with normal hip dysplasia tissues and
with tissues after mechanical loosening (Fig. 6d, e). Ca2+
content was also significantly increased as osteolysis
progressed (Fig. 6f). In addition, the data also suggested a
correlation between ER-stress intensity and the clinical
Fig. 4 Particles increased osteoclast numbers and VEGF
immunostaining. a–h Histochemical staining for TRAP in calvaria from
animals treated with various stimuli. Osteoclasts (arrowheads) were
identified according to histomorphologic criteria. Original
magnification: ×100. Bar 200 μm. a’–h’ Immunohistochemistry for
VEGF in periosteum tissues from animals treated with various stimuli.
Positively stained macrophages (arrowheads) and normal macrophages
(arrows) were identified according to histomorphologic criteria. Original
magnification: ×400. Bar 50 μm. Data represent the means ± SEM from
three independent experiments. *P<0.05, **P<0.01 versus control.
#P<0.05, ##P<0.01 versus TiNPs or CoNPs
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severity of osteolysis. Among these patients, the most se-
vere bone resorption, according to pre-operative radio-
graphs and intra-operative observation, was obtained in pa-
tient LOO1 (Fig. 6a, b). ER-stress intensity was also the
highest in this patient (Fig. 6d–f). However, IRE1-α,
GRP78/Bip and Ca2+ levels showed slight changes in the
patient with mechanical loosening relative to the control
(Fig. 6d–f). According to the integrated analysis, the ER-
stress pathway was involved in particle-induced osteolytic
interface membrane tissues during osteolysis, whereas the
clinical severity of osteolysis and ER-stress intensity were
inter-related.
Inflammatory response is aggravated by exacerbation
of osteolysis progression
Our results described above demonstrated that wear particles
in the osteolytic interface membrane are capable of inducing
Fig. 5 Osteoprotegerin (OPG) and receptor activator of nuclear kaapa B
(RANKL) expression levels in PIO animal models. a–h, a’–h’
Immunohistochemistry of OPG (a–h) and RANKL (a’–h’) in
periosteum tissues from animals treated with various stimuli. Positively
stained macrophages (arrowheads) and normal macrophages (arrows)
were identified according to histomorphologic criteria. Original
magnification: ×400. Bars 50 μm. a’’–d’’ Western blots of OPG and
RANKL in periosteum tissues performed after animals were treated
with various stimuli. The density of the Western blot bands was
quantified by using ImageJ software. Data represent the means ± SEM
from three independent experiments. *P<0.05, **P<0.01 versus control.
#P<0.05, ##P<0.01 versus TiNPs or CoNPs
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ER stress via IRE1α, GRP78/Bip and Ca2+ and of exacerbat-
ing bone resorption when phagocytosed by macrophages in
the periprosthetic space. Therefore, to investigate whether the
particle-induced osteolysis and ER stress described above are
relevant to the inflammatory response, we next assessed the
pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) expres-
sion (Fig. 6g–i), analyzed membrane erosion (Fig. 7a–i), ex-
amined c-Fos and NF-κB expression levels (Fig. 7j, k) and
assessed ROS release (Fig. 7l) in our patients.
Tissue levels of TNF-α, IL-1β and IL-6 were quantified by
ELISA and the results are shown in Fig. 6g–i. As expected,
low TNF-α, IL-1β and IL-6 expression levels were obtained
in normal hip dysplasia tissues and in tissues after mechanical
loosening. Osteolytic interface membrane tissues, however,
expressed robust amounts of TNF-α, IL-1β and IL-6
(Fig. 6g–i). Histological analysis of an HE-stained inter-
face membrane was used to assess membrane erosion
(Fig. 7a–i). The membrane remained smooth and intact
in normal hip dysplasia tissues and in tissues after me-
chanical loosening, whereas an increased membrane ero-
sion surface and decreased membrane thickness were ob-
served in osteolytic interface membrane tissues (Fig. 7a–
i). We then found that the c-Fos and NF-κB expression
levels in osteolytic interface membrane tissues were sig-
nificantly increased compared with normal hip dysplasia
tissues and with tissues after mechanical loosening
(Fig. 7j, k). This indicated that the c-Fos and NF-κB ex-
pression levels increased with the severity of osteolysis.
Additionally, ROS levels gradually increased with the ex-
acerbation of osteolysis (Fig. 7l).
Fig. 6 Pre-operative X-ray examination, tissue ultrastructure analysis,
ER stress and pro-inflammatory cytokines in interface membrane tissues
of patients with aseptic loosening (CON control, UNL unloose specimen,
LOO1–6 loose specimens 1–6). a, b Pre-operative radiographs of pa-
tients. c Ultrastructure of osteolytic interface membrane. Bar 500 nm.
Metal wear particles (arrowheads) and cellular structures (arrows) were
identified according to histomorphologic criteria. d, e IRE1α andGRP78/
Bip expression levels were increased in patients with aseptic loosening.
The density of the Western blot bands was quantified by using ImageJ
software. f-i Ca2+ content (f) and the expression of pro-inflammatory
cytokines TNF-α (g), IL-1β (h) and IL-6 (i) were increased in patients
with aseptic loosening. Data represent the means ± SEM from three
independent experiments.*P<0.05, **P<0.01 versus CON. #P<0.05,
##P<0.01 versus UNL
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Fig. 7 Up-regulation of membrane erosion, NF-κB and c-Fos expression
levels, ROS content, VEGF immunostaining, M-CSF content and TRAP
activity in patients with aseptic loosening (CON control, UNL unloose
specimen, LOO1–6 loose specimens 1–6). a–iMembrane erosion surface
was increased in patients with aseptic loosening. Original magnification:
×200. Bars 100 μm. j, k NF-κB and c-Fos expression levels were in-
creased in patients with aseptic loosening. The density of theWestern blot
bands was quantified by using ImageJ software. l ROS content was in-
creased in patients with aseptic loosening. a’–i’ Photomicrographs of
immunostaining in interface membrane tissues of patients with aseptic
loosening showing that several macrophages were positively labeled for
VEGF. Positively stained macrophages (arrowheads) and normal macro-
phages (arrows) were identified according to histomorphologic criteria.
Original magnification: ×400. Bars 50 μm. j’–l’ M-CSF content (j’) and
TRAP activity (k’) in interface membrane and TRAP activity in
osteolytic bone tissues (l’) were increased in patients with aseptic loosen-
ing. Data represent the means ± SEM from three independent experi-
ments. *P<0.05, **P<0.01 versus CON. #P<0.05, ##P<0.01 versus
UNL
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More importantly, we also found that the pro-inflammatory
cytokine contents (Fig. 6g–i), membrane erosion surface
(Fig. 7a–i), c-Fos and NF-κB expression levels (Fig. 7j, k)
and ROS concentration (Fig. 7l) shown above were in agree-
ment with each other and followed the same trend as ER stress
(Fig. 6d–f) and osteolysis symptoms (Fig. 6a, b). These find-
ings suggested that the particle-induced inflammatory re-
sponse in the osteolytic interface membrane significantly in-
creased with osteolysis progression, especially in the moder-
ate and severe stages of osteolysis compared with normal
tissues and with tissues after mechanical loosening. In addi-
tion, the clinical severity of osteolysis and ER-stress intensity
might have a certain relationship with the content and form of
the inflammatory response.
Up-regulation of osteoclastogenic molecules
with exacerbation of osteolysis
To investigate the potential involvement of osteoclastogenic
molecule activation in the osteolytic interface membrane, the
expression levels of the osteoclastogenic factors M-CSF,
VEGF, OPG and RANKL and the amounts of the osteoclast
maturation enzyme TRAP were quantified.
As depicted in Fig. 7f’–i’, significantly increased VEGF
immunostaining was observed with increasing osteolysis se-
verity and was consistent with the M-CSF levels (Fig. 7j’) and
TRAP activity data (Fig. 7k’, l’). The expression levels of
OPG and RANKLwere determined by immunohistochemical
staining (Fig. 8a–h, a’’) and Western blot (Fig. 8a’–h’, b’’). In
normal tissues, as expected, only low expression of OPG and
RANKL was detected. In the osteolysis stage, however, mac-
rophages in the osteolytic interface membrane showed robust
expression of RANKL accompanied by the slight expression
of OPG. Thus, our results described above suggest that the
osteoclastogenic molecules are significantly up-regulatedwith
the progression of osteolysis symptoms.
The wear particles were therefore capable of inducing
osteolysis and ER stress and were associated with the inflam-
matory response and the expression of osteoclastogenic mol-
ecules. The blocking of ER stress with 4-PBA dramatically
decreased particle-induced ER stress and osteolysis symp-
toms. Simultaneously, this ER-stress blocker also lessened
inflammatory cell infiltration, diminished the capability of os-
teoclastogenesis and reduced the inflammatory response
through the inhibition of specific biomarkers (IRE1α,
GRP78/Bip, c-Fos, NF-κB, ROS and Ca2+) of the ER-stress-
induced inflammatory signaling pathways.
Discussion
Aseptic loosening caused by osteolysis is a severe long-term
side-effect after joint replacement and can negatively affect
the longevity and prolonged efficacy of the prosthesis (Beck
et al. 2012; Park et al. 2005; Purdue et al. 2006). Therefore, an
understanding of the characteristics and loosening mecha-
nisms of joint replacement, specifically with respect to pre-
ventative action, is essential for the purpose of reducing the
prospective revision burden. Unfortunately, non-operative
therapy is mostly unavailable to resolve this process in the
earlier stages of periprosthetic osteolysis; only the radiological
proof of aseptic loosening necessitates revision surgery (Geng
et al. 2010a; Goodman et al. 2005; Mao et al. 2012). However,
with the improved comprehension of the molecular and cellu-
lar biological processes involved in particle-induced
osteolysis, pharmacological interventions targeting inflamma-
tion and osteoclastogenesis have emerged as promising ap-
proaches to recognize this detrimental process and to amelio-
rate the deterioration of artificial prosthesis at the molecular
level (Chen et al. 2012; Goodman et al. 2005; Ren et al. 2004,
2006a, 2010; Yang et al. 2012). Since the current prevention
and treatment methods of osteolysis are barely adequate, con-
siderable scientific investigation is required with regard to
alternative treatment options for the prevention and inhibition
of periprosthetic osteolysis.
The continuous enduring inflammatory osteolysis that fol-
lows total joint replacement has its origin in the repeated
inflammatory-cell-mediated phagocytosis of wear particles at
the bone/prosthesis interface and is characterized by the con-
stitution of the fibrous interface membrane around the loosen-
ing prosthesis (Ren et al. 2006b; Wang et al. 2004). Analysis
of the fibrous interface membrane revealed the domination of
macrophages, which represent 60–80 % of the whole cell
population (Gallo et al. 2014). Wear particles generated from
prostheses are phagocytosed by tissue-resident macrophages,
resulting in their activation, sustained stimulation and phago-
cytic effects and eventually leading to inflammatory response
and osteoclast differentiation. Accumulating evidence indi-
cates that particle-induced continuous inflammation and oste-
oclast differentiation are two decisive factors in the pathogen-
esis of osteolysis and aseptic loosening and that enhanced
osteoclastogenesis caused by the inflammatory response is
the final pathway of bone resorption (Chen et al. 2012;
Goodman et al. 2005; Ren et al. 2004, 2006a, 2010; Yang
et al. 2012). Since osteoclasts derive from the macrophages
lineage, various studies (Pandey et al. 1996; Quinn et al. 1992;
Sabokbar et al. 1997) have indicated that tissue-resident mac-
rophages and some macrophages recruited to the fibrous in-
terface membrane around loosening prostheses are capable of
differentiating into osteoclasts. Given that the activation of
macrophage is not limited to tissues surrounding the loosening
prosthesis but extends to the circulating monocytes in the
mononuclear phagocyte system, the chances are that macro-
phages represent both the Borigin^ and Bamplification^ of the
pathogenetic chain reaction in periprosthetic osteolysis.
Therefore, the interaction between macrophages and wear
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particles in the interface membrane around failed implants
might be alternatively considered a contributing detrimental
factor in osteolysis or a preventive element of osteolysis.
The local inflammatory response, whereby macrophages
represent the predominant cell-type, is recognized as a critical
mechanism leading to osteoclast differentiation and subse-
quent osteolysis (Abu-Amer et al. 2007; Goodman et al.
2013; Purdue et al. 2006). Many cellular signaling transduc-
tion pathways and cytokines have been demonstrated to be
related to the process of the inflammatory response but the
exact mechanism is still not comprehended. Recently, a batch
of signal pathways that target cellular stress have been distin-
guished (Hotamisligil 2010; McGuckin et al. 2010; Xu et al.
2005; Zhang and Kaufman 2008). Together, they are known
as ER-stress pathways and studies of ER stress have widened
the comprehension of the mechanisms bywhich inflammation
originates. Many studies suggest that ER-stress signaling
pathways and inflammation are interconnected through the
Fig. 8 Up-regulation of OPG and RANKL expression levels in interface
membrane tissues of patients with aseptic loosening (CON control, UNL
unloose specimen, LOO1–6 loose specimens 1–6). a–h, a’’, a’–h’, b’
Photomicrographs of immunostaining in interface membrane tissues of
patients with aseptic loosening showing that several macrophages were
positively labeled for OPG (a–h) and RANKL (a’–h’) and quantification
of OPG (a’’) and RANKL (b’’) expression levels. Positively stained
macrophages (arrowheads) and normal macrophages (arrows) were
identified according to histomorphological criteria. Original
magnification: ×400. Bars 50 μm. c’, d’ OPG and RANKL expression
levels were increased in patients with aseptic loosening. The density of
the Western blot bands was quantified by using ImageJ software. Data
represent the means ± SEM from three independent experiments.
*P<0.05, **P<0.01 versus CON. #P<0.05, ##P<0.01 versus UNL
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activation of the IRE1α/JNK/c-Fos-AP1 and NF-κB path-
ways, ROS production and the release of Ca2+ from the ER
(Hotamisligil 2010; McGuckin et al. 2010; Xu et al. 2005;
Zhang and Kaufman 2008) (Fig. 9). Notably, these signaling
pathways and mechanisms also play a principal role in
particle-induced inflammatory osteolysis. For instance, the
Ti-particle-induced release of TNF-α, IL-1β and IL-6 in mac-
rophages occurs via the activation of the JNK/AP-1 and
NF-κB pathways (Ren et al. 2004). Cell culture and in vivo
animal models (Kong et al. 2013; Liu et al. 2014; Nakashima
et al. 1999; Ren et al. 2004; Schwarz et al. 2000; Zhai et al.
2014) have confirmed that wear particles bring about the pro-
gression of inflammatory osteolysis by the activation of prin-
cipal pathways in macrophages, principally the NF-κB and
JNK/c-Fos-AP-1 signaling cascades. As previously reported
(Hotamisligil 2010; Zhang and Kaufman 2008), IRE1α is
probably critical for the integration of ER stress with inflam-
matory signaling via the activation of both JNK/c-Fos-AP-
1and NF-κB in response to ER stress. In addition, the
IRE1α, PERK andATF6 subfield of ER stress has been linked
to NF-κB signaling, suggesting that specific triggers of
inflammation act as signals via various branches of the ER-
stress pathway. Consistent with these findings, other studies
(Kong et al. 2013; Liu et al. 2014; Nakashima et al. 1999; Ren
et al. 2004; Schwarz et al. 2000; Zhai et al. 2014) have dem-
onstrated that inhibitory approaches targeting the NF-κB and
AP-1 signal transduction pathways ameliorate particle-
induced osteoclastogenesis, inflammation and osteolysis
in vitro and in vivo.
Inflammatory and osteoclastogenic pathways also have
crosslinks in their associated signaling cascades, including
the JNK/c-Fos-AP-1 and NF-κB pathways (Hotamisligil
2010; Zhang and Kaufman 2008). Meanwhile, other studies
(Cheng et al. 2010; Lin et al. 2014; Liu et al. 2014; Yamanaka
et al. 2011, 2013; Zhai et al. 2014) have shown that wear
particles induce osteoclastogenesis in part by the stimulation
of RANK and M-CSF and the activation of the NF-κB and
JNK pathways. These reports also indicate the feasibility of
the pharmaceutical and molecular blockade of the NF-κB and
JNK pathways to inhibit particle-induced osteoclastogenesis.
Previously (Liu et al. 2014; Yamanaka et al. 2013), the sup-
pression of JNK signaling has been shown to be able to inhibit
Fig. 9 ER-stress-mediated inflammatory signaling pathways proposed in
particle-induced periprosthesis osteolysis. Wear particles phagocytosed
by macrophages might induce ER stress and several potential avenues
might link ER stress and inflammatory signaling. Normally, the ER chap-
erone Grp78/BiP binds the N-termini of ER-stress sensors IRE1α, PERK
and ATF6, preventing their activation. In response to particle-induced ER
stress, Ca2+ is released from ER and Grp78/BiP preferentially binds to
unfolded or misfolded proteins, thus driving the equilibrium of Grp78/
BiP binding away from IRE1α, PERK and ATF6. Upregulation of these
genes triggers ER stress and thereby activates their downstreammediators
of inflammation and leads to the release of NF-κB, AP-1 and ROS. These
molecules move to the nucleus and switch on the expression of a variety
of genes involved in inflammation, such as TNF-α, IL-1β and IL-6,
leading to inflammatory responses
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particle-induced osteoclastogenesis and osteolysis and the
wear-particle induction of mature osteoclast formation from
RANKL-primed osteoclast precursor cells is suppressed by an
NF-κB depressor (Zhai et al. 2014). In agreement, we demon-
strated that the ER-stress inhibitor 4-PBA ameliorates particle-
induced inflammatory osteolysis and osteoclastogenesis by
inhibiting the NF-κB and JNK/c-Fos-AP-1 activation path-
ways and by suppressing the ER production of ROS and Ca2+.
Because of the function of macrophages as scavengers, the
protracted stimulation and repeated phagocytosis of wear par-
ticles will continuously activate the cellular machinery related
to intracellular degradation, such as lysosomes, peroxisomes
and proteolytic enzymes (Rae 1986). Thus, one of the direct
results of this process is the biogenesis and accumulation of
ROS and Ca2+ (Shanbhag et al. 1998; Tucci et al. 2000),
which could crucially affect polypeptide folding and chaper-
one function, initiating ER stress. However, enduring ER
stress might also lead to oxidative stress and Ca2+ imbalance,
inciting the accumulation of intracellular ROS and Ca2+ leak-
age from the ER; this might trigger the activation of NF-κB
and c-Fos-AP-1 signaling and initiate an inflammatory re-
sponse (Cullinan and Diehl 2006; Gorlach et al. 2006;
Hotamisligil 2010; Zhang and Kaufman 2008). Previous stud-
ies (Nakajima and Kitamura 2013; Raghunathan et al. 2013)
have provided evidence that ROS generation is induced by
various wear particles in macrophages. Localized ROS pro-
duction has also been implicated in eliciting cytokine over-
expression at the prosthesis/bone interface (Nakajima and
Kitamura 2013). However, the molecular mechanisms under-
lying ROS-induced ER stress and inflammation have not been
completely elucidated. Recent research (Zhang and Kaufman
2008) has demonstrated that ROS induces the depletion of the
Ca2+ store in ER via the suppression of Ca2+-ATPase, the
production and accumulation of oxidatively-modified proteins
and the functional perturbation of ER chaperones. These mo-
lecular events trigger the unfolded protein response, thereby
causing ER stress and leading to NF-κB and c-Fos-AP-1 reg-
ulation. Moreover, experiments (Pahl et al. 1996) with anti-
oxidants and Ca2+ chelators have revealed that Ca2+ and oxi-
dative stress signals bring about the activation of NF-κB in
reaction against ER stress. Consequently, ER-related NF-κB
and c-Fos-AP-1 activation might result from oxidative stress
and/or from the ER-stress-mediated release of Ca2+ into the
cytosol. Additionally, the Ca2+ leakage mediated by ER
stress is concentrated in the mitochondrial matrix and
results in the depolarization of the inner mitochondrial
membrane, the disruption of electron transport and the
increase in ROS production. ROS accumulation in mito-
chondrial can further promote Ca2+ release from ER by
sensitizing ER Ca2+-liberating channels and resulting in
ER stress. It is through such a forward cycle that the
continuous development of Ca2+ leakage, ROS genera-
tion and ER stress together activate Ca2+-dependent
protein kinases and the IRE1α/JNK/c-Fos-AP1 and
NF-κB pathways, exacerbating inflammatory responses
(Fig. 8).
In the present clinical experiments, we found that the levels
of the specific biomarkers of the ER-stress-mediated inflam-
matory signaling pathways (IRE1α, GRP78/Bip, c-Fos,
NF-κB, ROS and Ca2+), inflammatory factors (TNF-α, IL-
1β and IL-6), and osteoclastogenic molecules (VEGF, OPG,
RANKL and M-CSF) within the osteolytic interface mem-
brane all increase with the deterioration attributable to
osteolysis progression. These data indicate that the inflamma-
tory signaling pathway is involved in particle-induced
osteolysis; in addition, the ER-stress pathway, inflammatory
signaling pathway, osteoclastogenic reaction and clinical se-
verity of osteolysis are linked to one another.
Having established that wear particles indeed accelerate the
inflammatory response and ER stress in clinical situations, we
also explored its inductive effects under pathological
osteolysis conditions in a PIO animal model. We produced a
wear-particle-induced osteolysis animal model to validate the
necessary relationship between ER stress and particle-induced
inflammatory signaling pathways and directly to evaluate the
effects of ER stress on localized particle-induced osteolysis.
Based on our study aim, on previous studies (Billi and
Campbell 2010; Cobb and Schmalzreid 2006; Gill et al.
2012; Polyzois et al. 2012; Tsai et al. 2011; Wang et al.
2013) and on our TEM results, we introduced TiNPs and
CoNPs, with a mean particle diameter of 51.7 nm, into our
model.We demonstrated that the blocking of ER stress with 4-
PBA dramatically decreases particle-induced ER-stress inten-
sity and osteolysis symptoms in vivo. Interestingly, this ER-
stress blocker also lessens inflammatory cell infiltration, de-
creases the release of inflammatory factors (TNF-α, IL-1β
and IL-6), diminishes the capability of osteoclastogenesis by
suppressing the expression of osteoclastogenic cytokines
(VEGF, RANKL and M-CSF) and reduces the inflammatory
response through inhibition of the specific biomarkers of the
ER-stress-mediated inflammatory signaling pathways
(IRE1α, GRP78/Bip, c-Fos, NF-κB, ROS and Ca2+).
However, the effects discussed above are significantly aggra-
vated when the ER-stress inducer (Tg) is used in combination
with wear particles.
In addition, we found high-level OPG expression in the
normal group, whereas wear particles TiNPs and CoNPs can
reduce this reaction. RANKL is slightly elevated in the sham
surgery controls but is markedly increased in the TiNPs and
CoNPs groups, indicating that OPG does not confer protection
against bone resorption induced by wear particles. However,
RANKL or OPG cannot be used independently to evaluate
osteoclast differentiation, as the widespread coordination be-
tween them is indispensable to manage bone erosion. The
ability or inability of 4-PBA to induce RANKL expression
might be important in determining whether OPG is able to
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protect against particle-induced osteoclastogenesis. As ex-
pected, OPG expression is raised in the TiNPs or the CoNPs
plus 4-PBA co-treatment groups and yet protects against
particle-induced bone resorption; meanwhile, 4-PBA co-treat-
ment leads to reduced RANKL levels compared with those
exposed to particles with implantation. The decreased RANK
L levels together with the moderately increased OPG amounts
might be sufficient to shift the balance toward osteoclastogen-
esis. This property of 4-PBA might reduce the influence of
RANKL and diminish the excretion of pro-inflammatory and
pro-osteoclastogenic cytokines. These findings are consistent
with previous studies (Baumann et al. 2004; Granchi et al.
2004; Wang et al. 2010) demonstrating the reduction of
OPG secretion after particle stimulation but differ from obser-
vations describing an obvious secretion of OPG (Bylski et al.
2009; Mao et al. 2012; Ren et al. 2009). Given the differences
between the wear nanoparticles used here and the microparti-
cles of previous studies, we assume, like other researchers
(Baumann et al. 2004; Bylski et al. 2009; Granchi et al.
2004; Mao et al. 2012; Ren et al. 2009; Wang et al. 2010),
that the different compositions and physical characteristics of
wear particles affect the secretion of cytokines related to in-
flammatory osteolysis.
Great progress has been made in comprehending the sig-
naling pathways that integrate ER stress, apoptosis, inflamma-
tion, osteoclastogenesis and the physiological significances of
these associations. However, we still face many problems and
should continue to carry out intensive research to improve our
understanding of the interrelationship between them.
Recently, several studies (Clohisy et al. 2004; Geng et al.
2010a, 2010b; Jin et al. 2011; Kong et al. 2013;
Landgraeber et al. 2009, 2014; Lee et al. 2013; Liu et al.
2009, 2014; Mao et al. 2012; Wang et al. 2013; Zhai et al.
2014) have concentrated on exploiting efficacious medical
treatment for osteolysis by regulating the apoptotic, inflam-
matory and osteoclastogenic responses. However, modulation
of the interlinkage between these basic biological responses
for medical purposes, without giving rise to severe untoward
effects, is a considerable challenge. Since apoptosis, inflam-
mation and osteoclastogenesis interact with each other, any
independent action of one of these signaling pathways is im-
possible with respect to taking charge of the pathogenesis of
osteolysis. Given their complexity, the most effective way of
implementing changes would be to seek to re-establish bio-
logical homeostasis by regulating the incorporated functional
outcomes rather than the targeting of single pathways.
Recent studies (Boyce et al. 2005; Ozcan et al. 2006; Wang
et al. 2013) have suggested that the preservation or restoration
of ER function might be therapeutic in chronic metabolic dis-
eases. In our study, we demonstrated that ER stress stimulates
the induction of inflammatory reactions and subsequent
osteolysis as a result of particles in the osteolytic periosteum
tissues taken from PIO animal models and clinical specimens
of prosthesis loosening. The blocking of ER stress with 4-
PBA dramatically suppresses osteoclast differentiation, de-
creases inflammatory cytokine expression and reduces
osteolysis severity. Taken together, our findings provide a
proof of principle in a preclinical setting that the ER can be
chemically targeted to broaden its potential function and such
a strategy might open up attractive possibilities for preventa-
tive action and the treatment of patients with artificial joint
replacement who are at high risk of early inflammatory
osteolysis. Future studies should address the physiological
significance of the various ER-stress pathways in mediating
the inflammatory and osteoclastogenic response.
In the present study, we found that wear particles generated
at the implant interface can be distributed throughout the
periprosthetic milieu, can occupy adjacent tissues and can
accelerate ER-stress-mediated inf lammatory and
osteoclastogenic responses, eventually leading to
periprosthetic osteolysis. The blocking of ER stress with 4-
PBA dramatically decreases particle-induced ER-stress inten-
sity and osteolysis symptoms. Meanwhile, this ER-stress
blocker also lessens the infiltration of inflammatory cells, di-
minishes the capability of osteoclastogenesis and reduces the
inflammatory response through the inhibition of the specific
biomarkers (IRE1α, GRP78/Bip, c-Fos, NF-κB, ROS and
Ca2+) of the ER-stress-mediated inflammatory signaling path-
ways. The above results confirm that ER stress plays a signif-
icant role in particle-induced inflammatory osteolysis and
osteoclastogenic reactions. We present a diagram to show
the inflammatory signaling pathways mediated by ER stress
within the osteolytic interface membrane in particle-induced
periprosthetic osteolysis (Fig. 9). A fascinating prospect is
now opening up regarding pharmacological targeting by using
drugs for macrophages in the interface membrane and related
repair signaling pathways in the ER in order to alleviate prob-
lems in or even allow the regeneration of the damaged
periprosthetic tissues.
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